UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-12, Vol.33 (12), p.747-748

2021

Volltextzugriff (PDF)

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2014-01, Vol.32 (2), p.76-82

2014

Volltextzugriff (PDF)

Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-06, Vol.36 (6), p.362-369

2024

Volltextzugriff (PDF)

Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-04, Vol.32 (4), p.259-265

2020

Volltextzugriff (PDF)

SRAM FPGA Reliability Analysis for Harsh Radiation Environments

IEEE transactions on nuclear science, 2009-12, Vol.56 (6), p.3519-3526

2009

Volltextzugriff (PDF)

OC-0371: Introduction of a consultant radiographer to stereotactic radiotherapy service

Radiotherapy and oncology, 2016-04, Vol.119, p.S173-S173

2016

Volltextzugriff (PDF)

Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease

British journal of radiology, 2015-04, Vol.88 (1048), p.20140712

2015

Volltextzugriff (PDF)

Quality of Life after Radical Radiotherapy for Prostate Cancer: Longitudinal Study from a Randomised Trial of External Beam Radiotherapy Alone or in Combination with High Dose Rate Brachytherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-05, Vol.25 (5), p.321-327

2013

Volltextzugriff (PDF)

Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Annals of oncology, 2018-10, Vol.29, p.viii102-viii103

2018

Volltextzugriff (PDF)

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

British journal of cancer, 2006-02, Vol.94 (3), p.363-371

2006

Volltextzugriff (PDF)

Genomic profiling of circulating tumour DNA (ctDNA) and tumour tissue for the evaluation of rucaparib in metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2018-10, Vol.29, p.viii273-viii273

2018

Volltextzugriff (PDF)

Prostate Stereotactic Body Radiotherapy — First UK Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-12, Vol.26 (12), p.757-761

2014

Volltextzugriff (PDF)

Role of Stereotactic Body Radiotherapy (SBRT) in the Management of Oligometastatic (OM) Breast Carcinoma – UK Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-06, Vol.27 (6), p.e10-e10

2015

Volltextzugriff (PDF)

EP-1945: Plan submission comparison for commissioning of spinal and nodal SABR for oligometastases

Radiotherapy and oncology, 2016-04, Vol.119, p.S922-S923

2016

Volltextzugriff (PDF)

New Horizons and Hurdles for UK Radiotherapy: Can Prostate Stereotactic Body Radiotherapy Show the Way?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-01, Vol.26 (1), p.1-3

2014

Volltextzugriff (PDF)

EP-1295: Lymph node oligometastases treated with SABR: effect of dosimetric parameters on treatment outcomes

Radiotherapy and oncology, 2015-04, Vol.115, p.S698-S699

2015

Volltextzugriff (PDF)

First UK Prostate Stereotactic Body Radiotherapy (SBRT) Cohort: Prospective Outcomes with 2.5 Years’ Median Follow-up

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-05, Vol.28 (5), p.e11-e11

2016

Volltextzugriff (PDF)

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

The New England journal of medicine, 2023-02, Vol.388 (8), p.719-732

2023

Volltextzugriff (PDF)

OC-0263: HDR brachytherapy dosimetric predictors of biochemical control of prostate cancer

Radiotherapy and oncology, 2013-03, Vol.106, p.S102-S103

2013

Volltextzugriff (PDF)

179 Early outcome in patients with early stage non-small cell lung cancer treated with stereotactic body radiotherapy (Cyberknife): Mount Vernon Cancer Centre experience

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S61-S62

2013

Volltextzugriff (PDF)

First UK Cohort of Prostate Stereotactic Body Radiotherapy (SBRT): Acute Toxicity and Early Prostate-specific Antigen (PSA) Outcomes

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-02, Vol.26 (2), p.e7-e7

2014

Volltextzugriff (PDF)

OC-25 HIGH-DOSE RATE AFTERLOADING BRACHYTHERAPY USING ONE OR TWO FRACTIONS FOR LOCALISED PROSTATE CANCER

Radiotherapy and oncology, 2012-05, Vol.103, p.S10-S11

2012

Volltextzugriff (PDF)

OC-0051 QUALITY OF LIFE AFTER RADICAL RADIOTHERAPY FOR PROSTATE CANCER: RESULTS FROM A RANDOMISED TRIAL OF EBRT ± HDR-BT

Radiotherapy and oncology, 2012-05, Vol.103, p.S20-S20

2012

Volltextzugriff (PDF)

OC-0176: Biochemical control of large prostate glands treated with HDR-BT

Radiotherapy and oncology, 2013-03, Vol.106, p.S68-S69

2013

Volltextzugriff (PDF)

Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence)

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S365-S365

2013

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(189)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(70)
Humans
(54)
Male
(35)
Female
(31)
Biological And Medical Sciences
(29)
Hematology, Oncology And Palliative Medicine
(27)
Medical Sciences
(25)
Oncology
(24)
Adult
(22)
Middle Aged
(21)
Physical Sciences
(21)
Animals
(19)
Aged
(18)
Technology
(16)
Ophthalmology
(14)
Physics
(14)
Treatment Outcome
(14)
Radiology
(13)
Aged, 80 And Over
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience

Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer

SRAM FPGA Reliability Analysis for Harsh Radiation Environments

OC-0371: Introduction of a consultant radiographer to stereotactic radiotherapy service

Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease

Quality of Life after Radical Radiotherapy for Prostate Cancer: Longitudinal Study from a Randomised Trial of External Beam Radiotherapy Alone or in Combination with High Dose Rate Brachytherapy

Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

Genomic profiling of circulating tumour DNA (ctDNA) and tumour tissue for the evaluation of rucaparib in metastatic castration-resistant prostate cancer (mCRPC)

Prostate Stereotactic Body Radiotherapy — First UK Experience

Role of Stereotactic Body Radiotherapy (SBRT) in the Management of Oligometastatic (OM) Breast Carcinoma – UK Experience

EP-1945: Plan submission comparison for commissioning of spinal and nodal SABR for oligometastases

New Horizons and Hurdles for UK Radiotherapy: Can Prostate Stereotactic Body Radiotherapy Show the Way?

EP-1295: Lymph node oligometastases treated with SABR: effect of dosimetric parameters on treatment outcomes

First UK Prostate Stereotactic Body Radiotherapy (SBRT) Cohort: Prospective Outcomes with 2.5 Years’ Median Follow-up

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

OC-0263: HDR brachytherapy dosimetric predictors of biochemical control of prostate cancer

179 Early outcome in patients with early stage non-small cell lung cancer treated with stereotactic body radiotherapy (Cyberknife): Mount Vernon Cancer Centre experience

First UK Cohort of Prostate Stereotactic Body Radiotherapy (SBRT): Acute Toxicity and Early Prostate-specific Antigen (PSA) Outcomes

OC-25 HIGH-DOSE RATE AFTERLOADING BRACHYTHERAPY USING ONE OR TWO FRACTIONS FOR LOCALISED PROSTATE CANCER

OC-0051 QUALITY OF LIFE AFTER RADICAL RADIOTHERAPY FOR PROSTATE CANCER: RESULTS FROM A RANDOMISED TRIAL OF EBRT ± HDR-BT

OC-0176: Biochemical control of large prostate glands treated with HDR-BT

Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence)

Suchergebnisse filtern